GET DAILY SIGNALSEndava (DAVA): Weighing the Odds of Reaching the $4 Analyst Target
Key Takeaways
- The central target used in this analysis is $4.00, the arithmetic mean of five verified analyst price targets rounded from $3.90.
- Verified individual targets range from $2.00 to $5.00, a wide spread that reflects deep uncertainty about the company's future.
- At a recent price near $1.69, reaching $4.00 would require a rise of roughly 137%, a very large move for any equity.
- Supporting factors are limited to Endava's AI-focused strategy and its stated cash position of about £55 million as of September 30, 2026.
- The dominant risks are an accounting restatement, delayed financial filings, leadership turnover, securities litigation, and possible NYSE listing pressure.
- You can find more information on Endava's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages.
- To broaden your market view, explore Trending AI Robots for automated, AI-driven stock and ETF monitoring.
Analyst Price Targets and Consensus View
The $4.00 central target is the simple average of five attributed targets that could be verified with a firm, analyst, and date: Morgan Stanley (James Faucette) at $4.00 with a Hold rating dated November 9, 2026; Deutsche Bank at $2.00 with a Hold rating on September 22, 2026; TD Cowen (Bryan Bergin) at $3.50 with a Hold rating on July 9, 2026; and J.P. Morgan at $5.00 (Underweight) and Needham at $5.00 (Buy), both from late May 2026. The approximate range of these targets is $2.00 to $5.00.
That range is unusually wide, and the dispersion is meaningful. The most bearish targets reflect the September 2026 accounting revelations, while several higher targets predate them and may not yet incorporate the restatement risk. William Blair moved to a Sell-equivalent rating without a price target in September 2026, and Guggenheim downgraded the stock to Neutral in May 2026. Overall, the analyst consensus leans toward a cautious "Hold," with genuine disagreement between a lone Buy and the more defensive ratings. I also checked this using Tickeron’s AI Screener to see how DAVA compares to others in the industry.
Current Market Position and Path Toward the Target
Endava's ADS traded near $1.69 in early November 2026, just above its 52-week low of $1.52 and far below its 52-week high of $9.47. Reaching $4.00 would require a gain of roughly 137%, which is a very large move by any standard. The stock has shed more than 80% of its value over the trailing twelve months.
The path toward the target is complicated by the fact that Endava has withdrawn its fiscal 2026 guidance and delayed its annual report beyond its November 2, 2026 deadline. On October 28, 2026, the company said its audit committee investigation found that certain fiscal 2026 customer-and-supplier agreements "lacked economic substance," requiring a restatement of results with revenue adjustments equal to roughly 2% to 4% of prior-year revenue. Until audited figures are published, fundamental valuation of the stock is difficult, and the negative trailing EPS (earnings per share) leaves standard P/E (price-to-earnings) analysis of little use.
What Could Support a Move Toward the Target
The most concrete support is Endava's stated liquidity of approximately £55 million in cash as of September 30, 2026, which could give the company room to work through its restatement and remediation. Strategically, management continues to emphasize an AI-focused transformation and long-standing client relationships, which some analysts cite as a reason to expect a recovery if client demand stabilizes. A resolution of the accounting review, a credible restated balance sheet, and any sign that revenue attrition is slowing could prompt analysts to revisit their lower targets and improve sentiment toward the name.
What Could Prevent the Target From Being Reached
The obstacles are substantial. The company faces a securities class action with a November 30, 2026 lead-plaintiff deadline, an ongoing investigation, material weaknesses in internal controls over financial reporting, and the possibility that a restatement could affect compliance with debt covenants under its revolving credit facility. Leadership instability adds further risk: the CFO resigned, the CEO moved to a non-executive advisory role, and the General Counsel stepped down, with an interim CEO and interim CFO now in place. Perhaps most pressing, a share price near $1.69 sits uncomfortably close to the NYSE's threshold for delisting if the stock trades below $1.00 for an extended period. Client and employee confidence, already tested, could erode further as procurement decisions are delayed.
Technical Levels and Market Structure
From a technical standpoint, Endava is in a pronounced long-term downtrend. The shares broke down sharply on September 22, 2026, falling about 24% to close near $2.11 after the CFO was placed on administrative leave, and they have since drifted toward the $1.52 low. The $2.00 to $2.24 zone represents a notable prior breakdown area that could now act as resistance, and $2.79 marks the level just before the accounting disclosure. The psychological $1.00 level is the most important floor to monitor given listing rules, while $9.47, the 52-week high, remains a distant reference point rather than a near-term objective. I also reviewed recent patterns with Tickeron’s AI Real Time Patterns to confirm the downtrend structure.
Time Horizon and What Investors Should Monitor
Analyst price targets generally reflect a research horizon of roughly twelve months, though the precise horizon is not uniform across firms, and several of Endava's targets were set before the September 2026 disclosures. Key items to watch include the filing of restated fiscal 2026 results and the delayed annual report, any findings on credit-covenant compliance and lender discussions, the outcome of the securities litigation, the appointment of permanent executive leadership, and any further disclosure about client retention and revenue trends. An SEC or UK regulatory inquiry, while not yet announced, would be a material development if it emerged.
Integrating AI Signals for Better Context
For traders navigating a high-uncertainty name like Endava, I find Tickeron's AI Daily Buy/Sell Signals useful as a data-driven complement to fundamental research. The tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. In my process, it helps spot changing trends more efficiently than manual screening alone.
Final Assessment
Can Endava reach $4.00? The $4.00 level is not an official published consensus but the arithmetic mean of five verified analyst targets, rounded from $3.90, within a wide $2.00-to-$5.00 range. From roughly $1.69, that implies a very large move of about 137%. The strongest supports are the company's stated cash position and its AI-oriented strategy, while the principal obstacles are the accounting restatement, delayed filings, leadership turnover, litigation, and potential listing pressure. Given the wide analyst disagreement and the unresolved governance questions, the $4.00 target should be read as a reference point rather than a forecast, and the restated financials and leadership appointments will be the most important signals to watch.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
DAVA's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for DAVA turned positive on November 09, 2026. Looking at past instances where DAVA's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DAVA's RSI Indicator exited the oversold zone, 42 of 57 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 63 cases where DAVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Following a +8.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where DAVA advanced for three days, in 189 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
DAVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DAVA as a result. In 61 of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DAVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for DAVA entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.536) is normal, around the industry mean (16.360). P/E Ratio (-0.226) is within average values for comparable stocks, (53.310). Projected Growth (PEG Ratio) (0.266) is also within normal values, averaging (3.696). Dividend Yield (0.000) settles around the average of (0.434) among similar stocks. P/S Ratio (0.159) is also within normal values, averaging (104.492).
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. DAVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DAVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of information technology services
Industry ComputerCommunications
Advertisement